The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

A year after making its Super Bowl commercial debut, Pfizer is back with a 60-second spot for the 2025 game featuring a kid fighting cancer like a boxing champion. Set to LL Cool J's "Mama Said ...

As Angela Lukin, US president of global primary care at Pfizer, said: “Based on our current understanding, when we enter a traditional commercial model, anyone with commercial or government ...

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

Fonseca joined Pfizer in 2019, bringing more than 20 years ... need to work together to provide that experience. “In the commercial and medical space, digital medicines and digital health ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...

Pfizer Inc. shares fell 2% Tuesday despite ... year’s quarter driven by the company’s transition to traditional commercial market sales in the U.S. for the antiviral and by the revenue reversal.

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing.

Pfizer's adjusted EPS of $0.63 surpassed the ... reversal brought on by the company’s transition to traditional commercial market sales in the U.S. and away from government-related sales for ...

Pfizer PFE1.28%increase; green up pointing triangle had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So ...

Aamir Malik, who began leading Pfizer’s U.S. commercial business early last year, gave priority to turning around Nurtec. “We felt like there was a lot more that could be done," he said.